Morningside Venture Capital

Investor type Venture Capital
Founders Ken Shi Richard Liu

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 254
Average round size
info
The average size of a deal this fund participated in
$74M
Portfolio companies 146
Rounds per year 18.14
Lead investments 54
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.43
Exits 15
Key employees 4
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Artificial Intelligence
  • Internet
  • Software
  • Health Care
  • Biotechnology
Summary

Morningside Venture Capital is the famous VC, which was founded in 2008. The main department of described VC is located in the Xuhui. The venture was found in Asia in China.

The real fund results show that this VC is 11 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 7-12 investment rounds annually. The increased amount of exits for fund were in 2018. Comparing to the other companies, this Morningside Venture Capital performs on 21 percentage points less the average number of lead investments. Deals in the range of more than 100 millions dollars are the general things for fund. The typical startup value when the investment from Morningside Venture Capital is more than 1 billion dollars.

This organization was formed by Richard Liu. Besides them, we counted 4 critical employees of this fund in our database.

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Xiaomi, SenseTime, XPeng Motors. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Biopharma, Software. For fund there is a match between the location of its establishment and the land of its numerous investments - China.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Morningside Venture Capital, startups are often financed by Sequoia Capital China, Morningside Group, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, Gaorong Capital, GGV Capital. In the next rounds fund is usually obtained by Tiger Global Management, Sequoia Capital China, Tencent Holdings.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Access2net France, Ile-de-France, Paris
Atlas Capital LLC Arizona, Phoenix, United States
Biocartis Lausanne, Switzerland, Vaud
Blank Slate Ventures Chattanooga, Tennessee, United States
China Electronic System Technology -
Draper Investment Company Ad Dawhah, Doha, Qatar
Forever Young Capital -
FORWARD.one Venture Capital Netherlands, Noord-Holland, North Holland
Great Eagle Holdings Limited China, Hong Kong, Hong Kong Island
NewTech Capital Barcelona, Catalonia, Spain
Oceania Capital Partners Australia, Belrose, New South Wales
Pinama Investment Alcobendas, Madrid, Spain
Sage Group Newcastle upon Tyne, North East, United Kingdom
Shrieve Chemical Texas, The Woodlands, United States
Stellar Partners China, Guangdong, Shenzhen
Winfair Global -
Xinrui Zheshang Touzi China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

VisionNav Robotics

Automotive
Industrial
Robotics
$80M29 Apr 2022 Futian District, Guangdong Province, China

METiS Pharmaceuticals

Artificial Intelligence
$150M06 Apr 2022 Shangcheng District, Zhejiang, China

METiS Therapeutics

Biopharma
Biotechnology
Genetics
Health Care
$75M05 Apr 2022 Cambridge, Massachusetts, United States

Speedfox

$15M11 Mar 2022 Shenzhen, Guangdong, China

Regenerative Bio

Artificial Intelligence
Biotechnology
Health Care
Pharmaceutical
$10M25 Feb 2022 Cambridge, Massachusetts, United States

ReviR Therapeutics

Alternative Medicine
Biotechnology
Genetics
$20M17 Jan 2022 San Francisco, California, United States

Parametrix.ai

Artificial Intelligence
$100M04 Jan 2022 Futian District, Guangdong Province, China

Treelab

Collaboration
Enterprise Software
Information Technology
27 Dec 2021 San Francisco, California, United States

Xbiome

Artificial Intelligence
Biotechnology
Medical
Pharmaceutical
$100M22 Dec 2021 Futian District, Guangdong Province, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Morningside Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: